* Associate Professor of Pathology, Harvard Medical School

* Associate Director of Hematological, Molecular Pathology, Massachusetts General Hospital, Boston MA, USA

* Research on molecular characterization of myeloid neoplasms, focused to uncover underlying genetic driver mutations amenable to therapeutic intervention or responsible for acquired resistance to therapy

* Co-author of more than 170 articles

* Contributor to the 5th edition of The WHO classification of hematolymphoid tumors, 2022

* Professor of Oncological Pathology and Consultant Molecular Pathologist, Cambridge University Hospital NHS Foundation Trust, UK

* Editorial Board Member of the 5th edition WHO Hematolymphoid Tumors classification

* Author of more than 240 papers published in peer-reviewed Journals

* Active research in molecular pathology and genetics of marginal zone lymphoma, diffuse large B-cell lymphoma and nodal T follicular helper cells lymphoma

* Senior Associate Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Arizona, AZ USA

* Member of the Editorial Board of the WHO Reporting Systems for Liver Cytopathology

* Expert in inflammatory disorders of the gastrointestinal tract, pancreatobiliary tract, liver and cytopathology

* She has delivered lectures nationally and internationally and is the author of more than 30 papers published in peer-reviewed journals as well as several book chapters

* Department of Pathology, Academic Hospital “AOU L. Vanvitelli”, Naples, Italy

* Research focused on FNAC cytopathology, in particular on lymph node and extranodal pathology and corresponding standardized reporting system

* Member of expert panel of the WHO Reporting System for Lymph Node, Spleen and Thymus Cytopathology

* Author of 157 publications

* Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands

* Professor of Hematopathology, Amsterdam University, Medical Centers, Amsterdam, The Netherlands

* Member of the Expert Editorial Board of 5th edition of the WHO classification of hematolymphoid tumors, 2022

* Past-president of the European Association for Hematopathology (2018-2021)

* Author of more than 200 peer-reviewed papers and chapters in books

* Associate Professor of Hematopathology

* Senior Lecturer of Pathology, Lund University, Sweden

* Chair of the Swedish standardization group of hematopathology

* Member of expert panel and co-author of the WHO Reporting System for Lymph Node, Spleen and Thymus Cytopathology

* Organizer of multiple courses in hematopathology at national and international levels

* Co-author of more than 80 articles

Head and Neck Pathology Consultations, Woodland Hills, CA. Founding and Editor in Chief, Head and Neck Pathology Journal. Contributor in of WHO Tumor Classification Blue Books. He has published more than 270 research papers and six medical textbooks

Professor Fernando Schmitt is Professor of Pathology at the University of Porto, Senior Researcher and Head of Molecular Pathology Unit at IPATIMUP, President of the Portuguese Society of Cytology and General Secretary of the International Academy of Cytology (IAC). He has authored more than 435 papers in peer-review journals, 23 book chapters and he is editor of three books, one of molecular pathology, other of cytopathology and other of breast cytopathology.  Prof Schmitt is widely considered a world-leading expert in cytopathology and breast cancer. Fernando was a fellow at the Karolinska Medical Hospital, Stockholm, and was Professor of Pathology at the University of São Paulo (USP), Brazil and University of Toronto, Canada. He was also Director of the Department of Medicine at Laboratoire national de santé, Luxembourg. His research work is on breast cancer, with emphasis on molecular markers, cell adhesion and invasion, therapeutic targets and mechanisms of resistance. In the last years, his research work has been dedicated to the study of molecular markers on cytological material. Fernando serves as Associate Editor of six major scientific journals and sits on the editorial board of many others. He has also been chair, president or scientific director of several major European, Portuguese and Brazilian scientific societies of pathology and cytology. Currently he is the Secretary-General of the IAC. Fernando received the prize of Educator of the Year 2011 by the Papanicoloau Society of Cytology (USA), also received the prize GOLDBLATT AWARD 2013 from the International Academy of Cytology.

Graduate :

10/1979 – 01/1987 : University of Graz, School of Medicine (SOM)
1982 – 1987 : Demonstrator and study assistant, Department of Anatomy, Univ. of Graz, SOM
30.01.1987 : Graduation as MD (Dr. med. univ.), University of Graz, SOM
Training

01.02.1987 – 31.01.1993: Residency in Pathology , Dept. of Pathology, Univ. of Graz
Since 01.02.1993: Board certified for Pathology
Since 01.02.1995: Board certified for Pathology (Cytopathology)
01.10.1995 – 30.11.1997: Postdoctoral Research Fellowship (Erwin- Schroedinger-Scholarship of the Austrian Science Foundation), Department of Pathology Johns Hopkins University (Medical Institutions), Baltimore, MD (USA) with Prof. R.J. Kurman (Division of Gynecologic Pathology) and Lora H. Ellenson, MD, PHD (Molecular Research Laboratory).
20.01.1999 : Habilitation (Venia legendi and facultas docendi) for Pathology, University of Graz, School of Medicine.

01.03.1999: Associate Professor (tenured position), Department of Pathology, University of Graz
01.07.1999: Head of Working Group for Gynecological Pathology, Breast Pathology and Endocrine Pathology Department of Pathology, University of Graz
Since 01.11. 2000 Board certified for Pathology (Human Genetics)
Since 1.8. 2002 Head of the Department of Pathology, Hospital Graz Sud-West
2008 Professional title “University Professor“

Scientific Work

• 132 scientific articles (incl. review articles and letters) listed in PubMed, H-score 36, i10 index 63, about 4750 citations (according to Google scholar)
• 30 book chapters
• More than 200 invited lectures
• Supervision of graduate students and PH students (habilitation)
Member of Editorial Boards:
• 5th edition of the WHO blue books (2018-20)
• Virchows Archiv (Associate Editor)
• International Journal of Gynecological Pathology
• Der Pathologe
• Acta medicobiotechnica

Peer review activity for several scientific journals such as Virchows Archiv, International Journal of Gynecological Pathology, Gynecologic Oncology, International Journal of Cancer, European Journal of Cancer, International Journal of Gynecological Cancer, European Journal of Obstetrics and Gynaecology, Human Pathology, Der Pathologe, etc.

Membership of national and international scientific societies:
• Austrian Society of Pathology and Austrian Division of IAP
• Austrian Society of Surgery
• Austrian Society of Gastroenterology and Hepatology
• Austrian Society of Gynecology and Obstetrics
• Austrian Society of Senology
• Austrian Society of Surgical Oncology (ACO/ASSO)
• German Division of IAP
• German Society of Pathology (DGP)
• Endocrine Pathology Society
• European Society of Pathology (ESP)
• European Society of Surgical Oncology
• International Academy of Cytology
• International Society of Breast Pathology
• International Society of Gynecological Pathologists
• US and Canadian Academy of Pathology (USCAP)
Active functions as member of the following scientific associations:
• Past President of the German Division of IAP (2017-9)
• Council member Austrian Society of Pathology and Austrian Division of IAP (2017-8)
• Representative of the UEMS section Pathology
• Advisory board of the Austrian Ministry of Health for the National Cancer Plan
Former functions as member of the following scientific associations:
• President of the Austrian Society of Pathology and Austrian IAP division (2012-4)
• Speaker (Chair) of the OB/GYN and Breast pathology Working group of the German Society of Pathology (2005-17)
• Board member of the WHO consensus conferences 2002 and 2013 for Tumours of the Female Genital Tract
• Executive board member of ABCSG (Austrian Breast & Colorectal Cancer Study Group)
• Head of the scientific board of the tumour bank project of the ABCSG
• Executive board member International Society of Gynecological Pathologists 2004-2008
• Founding member of the GYN Pathology Working Group of the European Society of Pathology (2000)
Teaching
• Medical University Graz
• School of Medicine, University of Maribor/ Slovenia
• University of Applied Sciences (Fachhochschule) Graz: biomedical technologists
• University of Applied Sciences (Fachhochschule) Wiener Neustadt: cytotechnologists

Postgraduate Teaching:
 Seminars and Courses of the German Division of IAP, Austrian Society of Pathology and IAP Division, the European Society of Pathology, the International Society of Gynecological Pathologists and the International Academy of Pathology

Michael Wells is Emeritus Professor of Gynaecological Pathology, University of Sheffield. He retired in November 2014 and currently is a part-time Consultant Gynaecological Pathologist at Leeds Teaching Hospitals NHS Trust. He was Associate Professor in the Faculty of Medicine, University of Nice, 2016-2017. Mike is past-President of the British Gynaecological Cancer Society (1994-1997), the International Society of Gynecological Pathologists (2003-2005), the European Society of Pathology (ESP) (2009-2011) and the British Division of the International Academy of Pathology (BDIAP) (2012 – 2014) and Vice-President of the Royal College of Pathologists (2011-2014). He was editor of Histopathology (2002 – 2011). In 2004, he was elected a Fellow of the Royal College of Obstetricians and Gynaecologists (ad eundem) in recognition of the “major contributions he has made to the specialty and the wellbeing of women”. In November 2015, Mike was ranked second in “The Pathologist” magazine international inaugural “Top 100 Power List” of influential pathologists and laboratory medicine professionals.

Rodolfo Montironi, MD and IFCAP, obtained his medical degree at the Medical School of the University of Ancona, Italy in 1976, the board certificate in pathology and laboratory medicine at the University of Parma, Italy, in 1979, and the board certificate in clinical oncology at the University of Ancona in 1982. He received his advanced training in pathology in several British institutions under the supervision of world leaders in pathology, in particular at Hammersmith Hospital, London, UK, with Dr. John G. Azzopardi in 1979. He is International Fellow of the College of American Pathologists. He is Professor of Pathology at the Medical School of the Polytechnic University of the Marche Region, and Director of the Uropathology Program, United Hospitals, Ancona, Italy. He is a Past President of the International Society of Urological Pathology. He is the Chairman of the ESUP (EAU Section of Uropathology). He is a member of different international societies of pathology and of urology, including the European Society of Pathology and European Association of Urology. Dr Montironi’s work is centered on genitourinary tumor pathology. He is an author or coauthor of more than 700 publications in peer-reviewed international journals and of more than 30 chapters in books in the field of genitourinary tumor pathology. He has been a regular invited speaker at all major national and international pathology meetings. He organized and co-organized several international courses on genitourinary tumor pathology. Dr Montironi serves on the editorial boards of several international pathology and urology journals, including European Urology and European Urology Focus (Consulting Editor).

– Full-Professor of Anatomic Pathology, Córdoba University Medical School, Cordoba, Spain

– Director of Anatomic Pathology, Champalimaud Clinical Center, CCU, Lisbon, Portugal since July 2013-current

– Chairman, European Working Group on Urologic Pathology (section form European Society of Pathology)

– Member of the Experts Panel on Urologic Tumors who developed the 2016 WHO classification of Urologic Tumors (Book published 2016).

– Expert-scape Expertise in Urogenital Neoplasms Worldwide (2014/2017): Position 25 out of >75.217 experts.

– Over 500 publications in different aspects of Uropathology including several books on bladder and prostate pathology

Gladell P. Paner, MD, BS(MT) is an Associate Professor at the University of Chicago with a special interest and expertise in genitourinary pathology. Dr. Paner has been a speaker or has conducted courses in several renowned national and international medical associations such as the USCAP, AUA, CAP, ASCP, IAP and ESP and in 16 countries in 6 continents. Dr. Paner is a contributor to several genitourinary pathology practice guidelines and to the 2016 WHO classification of genitourinary tumors, and is currently the chair of the CAP Cancer Protocol Panel for Genitourinary Tumors, responsible for creating and reviewing the checklists for reporting cancer specimens from genitourinary organs. Dr. Paner has co-authored 4 books, several book chapters, and >95 peer-reviewed publications. Dr. Paner is the recipient of the prestigious Arthur Purdy Stout Award for 2016, awarded to recognize significant career achievements in Surgical Pathology by young surgical pathologists whose research publications have had a major impact on diagnostic pathology.

Dr. Puay Hoon Tan is Senior Consultant Histopathologist and Chairman, Division of Pathology, Singapore General Hospital, and Academic Chair of the SingHealth-Duke NUS Pathology Academic Program, Singapore. She is Professor of the Duke-NUS Medical School and Professor of the Departments of Anatomy and Pathology of the Yong Loo Lin School of Medicine, National University of Singapore. She has active interests in breast, urologic and renal pathology, and was a Volume Editor of the 2012 WHO Classification of Tumours of the Breast.  She sits on the Editorial Boards of Modern Pathology, Breast Cancer Research, Journal of Clinical Pathology, Pathology, Seminars in Diagnostic Pathology, and Analytical and Quantitative Cytology and Histology. She is Associate Editor of Histopathology and the Singapore Medical Journal. Apart from a busy service largely focused on subspecialty surgical signouts, she and her collaborators are recipients of several research grants related to translational studies of breast and prostate cancer. She is author of more than 400 publications, and participates regularly in regional and international meetings.

Dr Tan’s research interests in breast pathology centre around the classification of breast fibroepithelial lesions and their molecular pathogenesis, triple negative breast cancers, and ductal carcinoma in situ. In urologic pathology, she is engaged in prostate and renal cancer studies and is a contributor to the 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs.

She was a Past-President of the International Society of Breast Pathology, and was Councillor for Asia of the International Society of Urological Pathology (2009 – 2015).